Science and technology can and must play a role in devising solutions to this problem. It’s the burning process that creates the vast majority of the harmful and potentially harmful chemicals that are the primary causes of smoking-related diseases. Our goal is to offer current adult smokers who would otherwise continue smoking non-combustible, or smoke-free, alternatives that have the potential to reduce the risk of developing smoking-related diseases as compared to continued smoking.
One such alternative product – IQOS tobacco heating system – is currently under FDA’s MRTP review. On April 30, 2019, FDA authorized the marketing of IQOS in the U.S. Following a rigorous science-based review through the premarket tobacco product application (PMTA) pathway, the agency determined that authorizing these products for the U.S. market is appropriate for the protection of the public health.
The purpose of this site is to inform scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy about this review process and the data behind our application. This site is not for advertising or marketing, and it is not intended for use by consumers.
Our vision – for all of us at Philip Morris International – is that these breakthrough products will one day replace cigarettes.